|
GDSourcing's |
|
||
|
|
|
||
| Home | Search by Sector | Search by Subject | Advanced Search | Search by ID# | FREE TRIAL |
| About | Dead Links | Forgot Password | Help | SUBSCRIBE NOW | |
| ID #: | 39272604 | |||||||||||||||
| Title: | This information available to subscribers only. For more information click here | |||||||||||||||
| Source: | ||||||||||||||||
| Description: |
Profile of Canadian firms involved in the development and production of Bioproducts Includes: Bioproduct firms by length of time in operation and by length of time engaged in bioproducts related activity, Type of bioproduct by stage of development or production (e.g. Ethanol, Biodiesel, Solid Fuels (e.g., agri-straw pellets, agri-wood pellets, etc. [biofuel]), Bioenergy, Organic Chemicals, Bio-pesticides and Bio-catalysts Bioproducts firms by primary biomass source, Bioproduct firms by type of biomass supplier, Distance that the firm’s primary biomass was transported from its original source to the processing facility Revenues, costs and research and development (R&D) expenditures, bioproduct firms, Factors which influence firm’s decision to produce or develop bioproducts, Factors affecting the firm’s decision in locating a bioproducts facility Barriers to production or development of bioproducts, Bioproduct firms by means of initial involvement in the production or development of bioproducts Number of employees with bioproducts responsibilities by occupation activities, Factors affecting the firm’s efforts to fill bioproduct related job vacancies Bioproduct firms indicating bioproduct related activities that were contracted out (outsourced), Reasons invoked to contract out bioproduct related activities, Firms indicating they collaborated by type of partner, Reasons given by firm’s to collaborate with partners Bioproducts related patenting activities of bioproducts firms, by patent delivering office, Reasons provided by firms attempting to raise capital related to bioproducts in 2008 or 2009, Value of capital indicated by bioproduct firms as targeted and capital indicated that was raised for purposes related to bioproducts, Capital funds raised for bioproduct activities in bioproduct firms by funding source |
|||||||||||||||
| Publication Date: | 12/23/2011 | |||||||||||||||
| Frequency: | ||||||||||||||||
| Location Type: | Online | |||||||||||||||
| Geography: | Canada | |||||||||||||||
| Hyperlink 1: | This information available to subscribers only. For more information click here | |||||||||||||||
| Hyperlink 2: | ||||||||||||||||
| Location 1: | ||||||||||||||||
| Location 2: | ||||||||||||||||
| Notes: | ||||||||||||||||
| Posted/Updated: | 12/23/2011 | |||||||||||||||
| ID #: | 11058 | |||||||||||||||
| Title: | This information available to subscribers only. For more information click here | |||||||||||||||
| Source: | ||||||||||||||||
| Description: | Retail sales for Drugs and patent medicine stores by province and selected metropolitan areas. | |||||||||||||||
| Publication Date: | 12/21/2011 | |||||||||||||||
| Frequency: | Monthly | |||||||||||||||
| Location Type: | Online | |||||||||||||||
| Geography: | Canada, provinces, metropolitan areas | |||||||||||||||
| Hyperlink 1: | This information available to subscribers only. For more information click here | |||||||||||||||
| Hyperlink 2: | ||||||||||||||||
| Location 1: | ||||||||||||||||
| Location 2: | ||||||||||||||||
| Notes: | Hyperlink 1 to latest report. Hyperlink 2 to latest highlights. | |||||||||||||||
| Posted/Updated: | 12/21/2011 | |||||||||||||||
| ID #: | 39263152 | |||||||||||||||
| Title: | This information available to subscribers only. For more information click here | |||||||||||||||
| Source: | ||||||||||||||||
| Description: |
Key Information & Communication Technology (ICT) indicators for selected countries around the world (including Canada). Includes: Access lines and channels in total / per 100 inhabitants, Mobile subscribers in total / per 100 inhabitants (total and subscribers using prepaid cards) (cell phone), Internet Broadband subscribers (DSL/Cable) (high speed access), Availability of Digital Subscriber Lines (DSL), Households with access to the Internet, Households with access to a home computer [computer ownership] Internet penetration of businesses with 10 or more employees, Internet purchasing & selling by major industry grouping (Construction, Manufacturing, Real estate, renting & business activities, Transport, storage & communication, Wholesale & retail), Share of ICT-related occupations in the total economy, Share of ICT value added in the business sector value added, R&D expenditure in selected ICT industries ICT patents as a percentage of national total (EPO), Share of countries in ICT patents at the EPO, Trade in ICT goods, Contribution of ICT-using services to value added per person engaged, Contributions of ICT investment to GDP growth |
|||||||||||||||
| Publication Date: | 11/22/2011 | |||||||||||||||
| Frequency: | Annual | |||||||||||||||
| Location Type: | Online | |||||||||||||||
| Geography: | Canada, Selected countries | |||||||||||||||
| Hyperlink 1: | This information available to subscribers only. For more information click here | |||||||||||||||
| Hyperlink 2: | ||||||||||||||||
| Location 1: | ||||||||||||||||
| Location 2: | ||||||||||||||||
| Notes: | Source includes both graphs and data tables. The datasets are updated at different times over the year. | |||||||||||||||
| Posted/Updated: | 11/22/2011 | |||||||||||||||
| ID #: | 39260495 | |||||||||||||||
| Title: | This information available to subscribers only. For more information click here | |||||||||||||||
| Source: | ||||||||||||||||
| Description: |
Series of "snap shot" reports that compare Manitoba to Ontario, Saskatchewan, Alberta and B.C. Topics covered include: Employment (labour force data, unemployment, wages, female to male earnings, job creation) Social conditions (disposable income, personal debt, cost of living, crime, dependence on social safety net, youth at risk, health expenditures) Investment (patents per 1 million population, after tax profits to GDP, unit labour cost |
|||||||||||||||
| Publication Date: | 11/4/2011 | |||||||||||||||
| Frequency: | Annual | |||||||||||||||
| Location Type: | Online | |||||||||||||||
| Geography: | Manitoba, Canada, Ontario, Saskatchewan, Alberta, B.C. | |||||||||||||||
| Hyperlink 1: | This information available to subscribers only. For more information click here | |||||||||||||||
| Hyperlink 2: | ||||||||||||||||
| Location 1: | ||||||||||||||||
| Location 2: | ||||||||||||||||
| Notes: | Hyperlink to current report. Hyperlink 2 to archived reports. | |||||||||||||||
| Posted/Updated: | 11/4/2011 | |||||||||||||||
| ID #: | 39264129 | |||||||||||||||
| Title: | This information available to subscribers only. For more information click here | |||||||||||||||
| Source: | ||||||||||||||||
| Description: |
This report analyzes the total time patients must wait in Canada to gain access to newly invented pharmaceutical and biological medicines, also known as patented drugs. Includes: Average time spent waiting for Health Canada to approve new pharmaceutical and biological medicines (Compared to EU), Comparison of the average number of days spent waiting in Canadian provinces between Notice of Compliance and provincial reimbursement decision for new pharmaceutical and biological medicines reviewed by the Common Drug Review, Comparison of number of reimbursement approvals issued by Canadian provinces for new pharmaceutical and biological medicines reviewed by the Common Drug Review Total time spent waiting for after a new drug has been developed before patients have access to new pharmaceutical and biological medicines |
|||||||||||||||
| Publication Date: | 6/29/2011 | |||||||||||||||
| Frequency: | Annual | |||||||||||||||
| Location Type: | Online | |||||||||||||||
| Geography: | Canada, provinces | |||||||||||||||
| Hyperlink 1: | This information available to subscribers only. For more information click here | |||||||||||||||
| Hyperlink 2: | ||||||||||||||||
| Location 1: | ||||||||||||||||
| Location 2: | ||||||||||||||||
| Notes: | ||||||||||||||||
| Posted/Updated: | 6/29/2011 | |||||||||||||||